Esolate's formulation platform improves the stability, bioavailability, taste, and flavour of difficult actives — for pharmaceutical, nutraceutical, and CPG partners. This platform, backed by a portfolio of patents, patent-pending IP, and trade secrets, forms our Innovation Architecture.
We license and co-develop with partners who need consumer-ready delivery formats — without compromising on chemistry, stability, or compliance.
Engineered formulations and scale-up pathways for unstable or poorly bioavailable drug candidates — including reformulation of approved APIs into better-tolerated formats.
For pharma partners →
Effective, shelf-stable nutraceutical products where active dose actually survives the supply chain — from raw extract to finished SKU.
For wellness brands →
Beverages, edibles, topicals, and pet products with consistent active-ingredient delivery, masked taste and scent, and clean-label processing.
For CPG brands →Most active ingredients lose potency, taste bad, drift in flavour, or never reach the bloodstream. Our low-temperature platform addresses these in a single workflow.
Our low-temp process greatly reduces and mitigates API degradation during processing of distillates and isolates — heat- and oxidation-sensitive actives stay more intact.
Formulations resist degradation from heat, UV, and moisture, extending usable life across the entire distribution chain.
Our patented process increases the share of active ingredient that actually reaches systemic circulation.
Mask bitter or off-note profiles and stabilize flavour over the product's shelf life — what reaches the user matches what was intended.
Quick processing with no harsh solvents or chemicals — friendlier to actives, regulators, and labels.
Our IP portfolio supports powders, tablets, gels, liquids, and topicals — without re-engineering chemistry per SKU.
Esolate engineers two things in parallel: the innovative formulation itself, and the path that takes it from lab scale to commercial production. The platform is API-flexible and format-flexible — covering both the chemistry and the route to scale — so most of the development risk is taken off the table on day one.
Esolate is a Canadian biotech founded to solve a set of chemistry problems that hold back too many active ingredients — instability, low bioavailability, and a compromised end-user experience. Our innovation architecture gives pharmaceutical, nutraceutical, and CPG partners a formulation platform — not a one-off solution — to address difficult APIs across every SKU.
Meet the team →
Our exclusive pharmaceutical cannabinoid licensee announces a new partnership extending our platform into additional therapeutic applications.
Read announcement →
In an ever-evolving market, innovation is a necessity — not a buzzword. A look at how active-ingredient IP shapes the final consumer experience.
How taste, scent, and texture decisions interact with formulation chemistry to determine whether a finished product actually gets used.
Send us the API, the target format, and the problem you're trying to solve. We'll come back with a feasibility view and the right engagement model — licensing, custom formulation, or co-development.
